As I said in my introductory post to this series on the Map of Biomedicine, there’s incredible value in being to able to understand how things operate at a high level and also be able to drill down and see details. At the end of that post I showed a picture of the Map of Biomedicine that I’ve been working on. We’ll get back to talking about the overall map later, but for now I want to talk about some parts of the map in more detail. And just to answer one question up front: I’m sure this map will change. I’m guessing that in the process of writing these blog posts and fielding questions and comments, I’ll identify gaps and adjustments that will make the map more complete.
Read More
Tags:
map of biomedicine,
diagnostic test development,
diagnostics,
BRCA
It’s been a busy June. The air is thick with buzz about healthcare data, information and engagement from both the business and consumer sides of the healthcare coin. During the first month of summer 5AM and our partners and customers saw, heard, read , and -- in some cases -- ushered in signs of momentum toward patient-centered care. Here’s our short list:
Read More
Tags:
personalized medicine,
data,
OpenFDA
The world’s largest and most influential biotechnology gathering, the 2014 BIO International Conference, kicks off today in San Diego. BIO, the signature annual event of the Biotechnology Industry Organization (BIO) convenes biotech innovators and influencers from around the globe to explore solutions and meet service providers; gain new perspectives from thoughtful and thought-provoking leaders; find new partners and evaluate projects at all phases of development.
Read More
Tags:
biotechnology conference,
5AM customers
In an article in Nature Medicine, Craig Lipset, Pfizer's head of Clinical Innovation for Worldwide Research, points out the elephant in the lab when it comes to modern clinical trials and social networking:
Read More
Tags:
clinical trials,
social media,
5AM customers
DIA kicked off its 50th Annual Meeting in San Diego, yesterday, where the theme is "Celebrate the Past - Invent the Future." The future (or part of it, anyway) seems to have arrived at DIA 2014 where, from keynote to closing, patient advocates have a prominent seat at the head of the table; a table previously reserved for health care professionals. It makes us hopeful: is the personalized, patient-centered future here?
Read More
Tags:
cancer,
clinical trials,
personalized medicine,
cancer studies
Who doesn’t like a scientific breakthrough? The media buzzes with news from the frontiers of science that directly affects us: biological and medical research. The stories that really get our attention are those in which new technologies solve medical mysteries or save lives.
Read More
Tags:
cancer,
clinical trials,
DNA sequencing,
DNA,
biomedicine,
map of biomedicine
Imagine the worst: you’ve been shot, and your chances of survival are dismally slim. It goes without saying that when rushed to the ER, you’re unconscious.
Read More
Tags:
EHR,
electronic health records,
health IT,
EMR,
informed consent,
consent,
clinical trials
It is easy to get nostalgic for the good old days. The always “on” pace of modern life makes us long for simpler times. Times, we imagine, that were more innocent; times with fresher air, tastier food, and enough leisure to make you slightly eager to get back to work.
Read More
Tags:
clinical trials,
clinical research
Yesterday, at Health Datapalooza, United States CTO, Todd Park, announced that the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) had launched initiatives that make tons of much-requested — but hard to get — health data accessible to the public.
Read More
Tags:
health IT,
clinical trials,
personalized medicine,
Big Data,
Data Science,
FDA
